HSBA

1,445.6

+0.54%↑

BARC

517

+1%↑

LLOY

109.6

+1.11%↑

STAN

2,055

+0.05%↑

FERG.UK

18,000

+1.24%↑

HSBA

1,445.6

+0.54%↑

BARC

517

+1%↑

LLOY

109.6

+1.11%↑

STAN

2,055

+0.05%↑

FERG.UK

18,000

+1.24%↑

HSBA

1,445.6

+0.54%↑

BARC

517

+1%↑

LLOY

109.6

+1.11%↑

STAN

2,055

+0.05%↑

FERG.UK

18,000

+1.24%↑

HSBA

1,445.6

+0.54%↑

BARC

517

+1%↑

LLOY

109.6

+1.11%↑

STAN

2,055

+0.05%↑

FERG.UK

18,000

+1.24%↑

HSBA

1,445.6

+0.54%↑

BARC

517

+1%↑

LLOY

109.6

+1.11%↑

STAN

2,055

+0.05%↑

FERG.UK

18,000

+1.24%↑

Search

ConvaTec Group PLC

Nyitva

SzektorPénzügy

210.2 3.04

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

204

Maximum

210.8

Fő mutatók

By Trading Economics

Bevétel

-34M

71M

Értékesítés

85M

1.3B

P/E

Szektor átlag

29.8

22.989

Egy részvényre jutó nyereség

0.08

Osztalékhozam

3.47

Profit margin

5.575

Munkavállalók

10,910

EBITDA

57M

338M

Ajánlások

By TipRanks

Ajánlások

Erős vétel

12 hónapos előrejelzés

+44.01% upside

Osztalékok

By Acuity

Osztalékhozam

Szektor átlag

3.47%

4.69%

Következő eredményjelentés

2026. aug. 4.

Következő korábbi osztalék dátum

2026. aug. 20.

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

-793M

4.1B

Előző nyitás

207.16

Előző zárás

210.2

Hangulat hírek alapján

By Acuity

50%

50%

157 / 439 Rangsor szerint Finance

ConvaTec Group PLC Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Rólunk ConvaTec Group PLC

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other causes, as well as critical care devices and products used in intensive care units and hospital settings. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for pumps used in continuous subcutaneous infusion treatments for conditions such as parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.
help-icon Live chat